[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Brain Health Alliance\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100392439","early-phase-1-entire-body-pet-scans-for-multiple-sclerosis-100392439",false,"NCT04390009","Entire-body PET Scans for Multiple Sclerosis","Exploratory Study of Entire-body PET Scans for Multiple Sclerosis","EPSMS","Inclusion Criteria:\n\n* Multiple sclerosis (MS) patients diagnosed by a credentialed neurologist experienced with care of multiple sclerosis patients.\n* Normal healthy subjects.\n* Willing and able to lie motionless on the PET-CT scanner bed for at least 10 minutes and up to 20 minutes for the duration of the PET-CT medical imaging scan.\n\nExclusion Criteria:\n\n* Any additional complicating medical illness other than MS including any other neuropsychiatric illness unrelated to MS diagnosed prior to the onset of initial symptoms of MS.\n* Pregnancy or breast feeding.\n* Diabetes or other metabolic-endocrine disorders.\n* Any known concomitant acute infection.\n* History of metastatic or locally invasive cancer.\n* Recent surgery, chemotherapy or radiation therapy.",true,"ALL","25 Years","55 Years",{"count":22,"type":23},20,"ESTIMATED","INTERVENTIONAL",[26],"EARLY_PHASE1","To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.",[29],"Multiple Sclerosis",[29,31],"Entire-body PET imaging","RECRUITING","2026-10-02",{"date":35,"type":36},"2026-10-06","ACTUAL",{"date":38,"type":36},"2024-09-30",{"date":40,"type":23},"2028-06-30",{"name":42,"class":43},"Brain Health Alliance","OTHER",""]